英文名稱 |
中文名稱 |
CAS號 |
操作 |
Dasatinib carbaldehyde |
|
2112837-79-1 |
詳細(xì)
|
LY392098 |
|
211311-39-6 |
詳細(xì)
|
NHWD-870 |
|
2115742-03-3 |
詳細(xì)
|
Fanotaprim |
|
2120282-75-7 |
詳細(xì)
|
Eclitasertib |
|
2125450-76-0 |
詳細(xì)
|
PXS-5120A |
|
2125955-70-4 |
詳細(xì)
|
PXS-5153A |
|
2125956-82-1 |
詳細(xì)
|
Vepafestinib |
|
2129515-96-2 |
詳細(xì)
|
CPD2028 |
|
2131091-31-9 |
詳細(xì)
|
Ralmitaront |
|
2133417-13-5 |
詳細(xì)
|
Almonertinib mesylate |
|
2134096-06-1 |
詳細(xì)
|
2-Pyrimidinamine, 4-(5-bromo-1H-indol-3-yl)- |
|
213473-00-8 |
詳細(xì)
|
MAGL-IN-4 |
|
2135785-20-3 |
詳細(xì)
|
2-Pyridinecarboxamide, 4-[[6-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]iminomethyl]amino]-3-pyridinyl]oxy]-N-methyl- |
|
2136278-38-9 |
詳細(xì)
|
SERCA2a activator 1 |
|
2139330-34-8 |
詳細(xì)
|
Thalidomide-NH-C2-PEG3-OH |
|
2140807-23-2 |
詳細(xì)
|
Pomalidomide-PEG3-OH |
|
2140807-36-7 |
詳細(xì)
|
Pomalidomide-PEG2-OH |
|
2143097-10-1 |
詳細(xì)
|
(Rac)-X77 |
|
2144491-78-9 |
詳細(xì)
|
Zandatrigine |
|
2154406-04-7 |
詳細(xì)
|
Cedirogant |
|
2055496-11-0 |
詳細(xì)
|
HPK1-IN-2 dihydrochloride |
|
2056122-11-1 |
詳細(xì)
|
BETA-CFT sulfate |
|
2068138-14-5 |
詳細(xì)
|
NLG802 |
|
2071683-99-1 |
詳細(xì)
|
SBI993 |
|
2073059-56-8 |
詳細(xì)
|
MBM-55 |
|
2083622-09-5 |
詳細(xì)
|
MBM-55S |
|
2083624-07-9 |
詳細(xì)
|
SRI-29329 |
|
2086809-58-5 |
詳細(xì)
|
EST64454 Maleic acid salt |
|
2088272-67-5 |
詳細(xì)
|
Selective PI3Kδ Inhibitor 1 |
|
2088525-31-7 |
詳細(xì)
|
FLT3-IN-10 |
|
2088735-51-5 |
詳細(xì)
|
CHMFL-EGFR-202 |
|
2089381-40-6 |
詳細(xì)
|
ZINC-3573 |
|
2089389-15-9 |
詳細(xì)
|
PQM130 |
|
2089415-51-8 |
詳細(xì)
|
1,3,3,5,5-pentamethylcyclohexan-1-amine hydrochloride |
|
209185-99-9 |
詳細(xì)
|
CYP17-IN-1 |
|
2093317-51-0 |
詳細(xì)
|
Pomalidomide-C7-NH2 hydrochloride |
|
2093387-55-2 |
詳細(xì)
|
KY-02327 |
|
2093407-25-9 |
詳細(xì)
|
2-(2,6-dioxopiperidin-3-yl)-4-((7-hydroxyheptyl)oxy)isoindoline-1,3-dione |
|
2093536-10-6 |
詳細(xì)
|
THZ1 2HCl |
|
2095433-94-4 |
詳細(xì)
|
MELK-IN-1 |
|
2095596-44-2 |
詳細(xì)
|
Lu AF27139 |
|
2097117-06-9 |
詳細(xì)
|
HM-30181 mesylate monohydrate |
|
2097125-58-9 |
詳細(xì)
|
CHK1-IN-3 |
|
2097252-39-4 |
詳細(xì)
|
N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-5-ethyl-6-[ethyl(tetrahydropyran-4-yl)amino]-2-(1-piperidylmethyl)benzofuran-4-carboxamide |
|
2098545-98-1 |
詳細(xì)
|
Thalidomide-PEG4-Propargyl |
|
2098799-77-8 |
詳細(xì)
|
TRPM8 antagonist 3 |
|
2102179-29-1 |
詳細(xì)
|
Brr2-IN-3 |
|
2104030-82-0 |
詳細(xì)
|
(S,R,S)-AHPC |
|
2055344-67-5 |
詳細(xì)
|
Obafistat |
|
2160582-57-8 |
詳細(xì)
|
4-(4,5-dibromo-6-oxo-1,6-dihydropyridazin-1-yl)benzene-1-sulfonamide |
|
2163817-03-4 |
詳細(xì)
|
TAS1553 |
|
2166023-31-8 |
詳細(xì)
|
Et-29 |
|
2166487-23-4 |
詳細(xì)
|
JNJ-55308942 |
|
2166558-11-6 |
詳細(xì)
|
ZL0590 |
|
2230496-99-6 |
詳細(xì)
|
ARN-21934 |
|
2230854-93-8 |
詳細(xì)
|
NCT-505 |
|
2231079-74-4 |
詳細(xì)
|
JI130 |
|
2234271-86-2 |
詳細(xì)
|
ethyl 1-(4-aminophenyl)-5-(trifluoromethyl)-1H-pyrazole-4-carboxylate |
|
223500-15-0 |
詳細(xì)
|
SI-2 |
|
223788-33-8 |
詳細(xì)
|
Methuosis inducer 1 |
|
2240205-30-3 |
詳細(xì)
|
4-Pyridinecarboxaldehyde, 2-(2-pyridinyl)hydrazone, [C(E)]- |
|
2241017-37-6 |
詳細(xì)
|
AZ194 |
|
2241651-99-8 |
詳細(xì)
|
ASP2453 |
|
2241719-73-1 |
詳細(xì)
|
VPC-18005 |
|
2242480-48-2 |
詳細(xì)
|
USP30 inhibitor 18 |
|
2242582-40-5 |
詳細(xì)
|
Methyl maslinate |
|
22425-82-7 |
詳細(xì)
|
Acoramidis hydrochloride |
|
2242751-53-5 |
詳細(xì)
|
DW14800 |
|
2243709-60-4 |
詳細(xì)
|
MUN36378 |
|
2243736-37-8 |
詳細(xì)
|
Rimtuzalcap |
|
2167246-24-2 |
詳細(xì)
|
NS3861 |
|
216853-59-7 |
詳細(xì)
|
3-(3-Bromo-2-thienyl)-8-methyl-8-azabicyclo[3.2.1]oct-2-ene fumarate |
|
216853-60-0 |
詳細(xì)
|
SOD1-Derlin-1 inhibitor 56-59 |
|
2170170-27-9 |
詳細(xì)
|
RORγt inverse agonist 13 |
|
2170477-75-3 |
詳細(xì)
|
MAK-683 hydrochloride |
|
2170606-94-5 |
詳細(xì)
|
1H-Pyrazole-5-carboxamide, 4-(5-chloro-2-furanyl)-1,3-bis(2,4-difluorophenyl)-4,5-dihydro-5-methyl-N-[(4-methyl-2-morpholinyl)methyl] |
|
2171015-78-2 |
詳細(xì)
|
cjoc42 |
|
2171519-89-2 |
詳細(xì)
|
Inarigivir ammonium |
|
2172788-92-8 |
詳細(xì)
|
Paltusotine |
|
2172870-89-0 |
詳細(xì)
|
2,5-Morpholinedione, 4-methyl-6-(1-methylethyl)-3-(phenylmethyl)- |
|
2180287-51-6 |
詳細(xì)
|
VPC-13566 |
|
218464-59-6 |
詳細(xì)
|
1-benzyl-2-ethyl-4,5,6,7-tetrahydro-1H-indol-4-one |
|
218934-50-0 |
詳細(xì)
|
N-(2-{bis[2-(2,2-dichloroacetamido)ethyl]amino}ethyl)-2,2-dichloroacetamide hydrochloride |
|
2193060-78-3 |
詳細(xì)
|
1,1'-(Heptane-1,7-diyl)diguanidine dihydrochloride |
|
2193061-39-9 |
詳細(xì)
|
(+/-)-Longamide |
|
219783-00-3 |
詳細(xì)
|
SHP099 hydrochloride |
|
2200214-93-1 |
詳細(xì)
|
Isolugrandoside |
|
221660-27-1 |
詳細(xì)
|
CD73-IN-4 |
|
2216764-29-1 |
詳細(xì)
|
Dazcapistat |
|
2221010-42-8 |
詳細(xì)
|
(1S,2R)-Alicapistat |
|
2221010-57-5 |
詳細(xì)
|
ARD-2128 |
|
2222111-87-5 |
詳細(xì)
|
ATG7-IN-1 |
|
2226229-87-2 |
詳細(xì)
|
Dynapyrazole A |
|
2226517-75-3 |
詳細(xì)
|
NPT200-11 |
|
2227057-23-8 |
詳細(xì)
|
AS-1763 |
|
2227211-00-7 |
詳細(xì)
|
EGFR-IN-1 hydrochloride |
|
2227455-78-7 |
詳細(xì)
|
SLC13A5-IN-1 |
|
2227548-95-8 |
詳細(xì)
|
PKCiota-IN-2 |
|
2230055-52-2 |
詳細(xì)
|
JNJ-67856633 |
|
2230273-76-2 |
詳細(xì)
|